MedPath

苏州朗科生物技术股份有限公司

Ownership
-
Established
2010-09-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Escitalopram Oxalate Oral Solution

Product Name
草酸艾司西酞普兰口服溶液
Approval Number
国药准字H20253930
Approval Date
Apr 15, 2025
NMPA

Magnesium Sulfate,Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution

Product Name
硫酸镁钠钾口服用浓溶液
Approval Number
国药准字H20253542
Approval Date
Mar 4, 2025
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20243418
Approval Date
Mar 29, 2024
NMPA

Paricalcitol Injection

Product Name
帕立骨化醇注射液
Approval Number
国药准字H20223304
Approval Date
May 10, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.